• Principal Investigator:
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11507004). Association between Myosteatosis and Heterogeneous Risks of Geriatric Syndromes in Older Adults with Diabetes: Sugroup Effect Evaluation Using Counterfactual Framework and Machine Learning (老年糖尿病患者之肌肉脂肪變性與老年病症候群異質性風險探討：結合反事實架構與機器學習之次群體效果評估). NT$ 150,000 (2026/1-2026/12).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11407001). Meta-Learning Approach Based on the Counterfactual Framework for Estimating Conditional Average Treatment Effects (CATE): Application of Real-World Comparative Effectiveness Research (基於反事實架構的後設學習方法，用於估計條件平均治療效果(CATE)：真實世界醫藥效益比較研究應用). NT$ 150,000 (2025/1-2025/12).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11307007). Cheng Kung University Hospital Academic Research Database (CARD): An Institutional Electronic Medical Record for Real-World Medical Research (成醫學術研究資料庫(CARD)：基於真實世界證據之電子病歷資料庫). NT$ 135,000 (2024/1-2024/12).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11207009). A machine learning approach to develop generalized propensity score matching for multiple treatments: application to claim data study (運用機器學習發展多治療組之廣義傾向分數配對方法與臨床應用研究). NT$ 132,750 (2023/1-2023/12).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11007021). Comparative risk of Clostridium difficile infection and days of proton pump inhibitors and H2-blockers use in hospital inpatients (住院病房氫離子幫浦抑制劑與第二型抗組織胺受體拮抗劑的使用天數與發生困難梭狀桿菌感染之風險比較研究). NT$ 100,000 (2021/1-2021/12).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-10905021). The use of proton pump inhibitors and the risk for hospital-acquired pneumonia and Clostridium difficile infection in intensive care units (加護病房氫離子幫浦抑制劑與發生院內感染型肺炎及困難縮狀桿菌感染危險之相關性探討). NT$ 95,000 (2020/1-2020/12).
  • Co-investigator:
    • National Science and Technology Council, Taiwan (114-2320-B-075B-003 -). Constructing a risk factor and cost-effectiveness model for mortality in colorectal cancer with transferability: Integrating simulation target trials with machine learning and modeling approaches in the study of clinical big data for healthcare and health insurance policies in Taiwan (建構轉移性大腸直腸癌死亡之危險因子與成本效益模型，以提供台灣於疾病照護與健保政策之參酌: 透過模擬目標試驗結合機器學習與模型方法於臨床大數據之研究). NT$ 1,500,000 (2025/8-2026/07).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11403041). 精神疾患中的加速老化現象：整合各器官生理變化以建立生命歷程之軌跡模型. (2025/1-2025/12).
    • National Cheng Kung University Hospital, Taiwan (NCKUH-11403024). 腹部電腦斷層揭秘：身體組成與乳癌預後之關聯性及因果關係探討. (2025/1-2025/12).
    • National Science and Technology Council, Taiwan. Development and Evaluation of the CARE Mobile-learning System to Improve Professional Engagement among Newly Hired Nurses (研發與實證CARE行動式學習系統強化新進護理師專業投入之成效). NT$ 863,000 (2024/8-2025/7).
    • National Science and Technology Council, Taiwan. The Feasibility and Effects of Exercise Training Combined with Blood Flow Restriction (血流限制合併運動訓練對於慢性腎臟疾病患者運動能力、運動耐受性之效果可行性探討). NT$ 880,000 (2024/8-2025/7).
    • Quanta-NCKU Joint AI Research Center (廣達-成大聯合AI研究中心). A Pipeline to Combine Clustering and Regression/Classifier for Health Outcome Prediction (結合集群分析與迴歸或分類器於健康結果預測). NT$ 1337728 (2022/8/1-2024/10/31).